EMPIRE INSURANCE CO | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (29)

View All

Latest Posts

About This Stock More About This Stock
Attention Biotech Investors: Mark Your Calendar For Dec. PDUFA Dates
Article By: Benzinga
Saturday, November 28, 2020 3:50 PM EDT
The U.S. Food and Drug Administration's approval machinery churned out a lot of disappointments in November. Most of the negative verdicts were tied to difficulties the agency had in inspecting facilities where drugs are being manufactured.
In this article: SNY, ADMP, EIGR, ALNY, BCRX, VNDA, ALKS, SUPN, RVNC, LQDA
Read
The Week Ahead In Biotech: The Vaccine Updates, Drug Presentations, And FDA Decisions That Will Move The Markets
Article By: Benzinga
Sunday, November 15, 2020 2:46 PM EDT
Biotech stocks advanced in the week ended November 13 amid a vaccine news flow-induced rally that also lifted the broader market. The week started with positive tidings from Pfizer Inc. and its German partner BioNTech SE – ADR.
In this article: BMY, PFE, EIGR, ALKS, BIIB, MYL, MRNA, SUPN, FPRX, BNTX
Read
The Week Ahead In Biotech (Aug. 24-29): Lipocine Binary Event, Liver Congress In The Spotlight
Article By: Benzinga
Sunday, August 23, 2020 3:17 PM EDT
After seeing strength earlier, biotech stocks came under pressure in the past week. With the earnings season tapering and not much noise on the coronavirus front, the sector reacted to clinical readouts, M&A announcements, and adverse FDA rulings.
In this article: EIGR, ARWR, CBAY, VKTX, ADAP, ASMB, LPCN, MIRM, AXLA
Read
Morning Call For Wednesday, Oct. 17
Article By: Jim Van Meerten
Wednesday, October 17, 2018 8:01 AM EDT
Dec E-mini S&Ps (ESZ18 -0.31%) this morning are down -0.25% ahead of the FOMC meeting. European stocks are down -0.09%, led by losses in automakers.
In this article: IBM, KBH, UAL, EIGR, CREE, IBKR, LRCX, NFLX, NTAP, UFPI, VICR, TACO, SPOT, ROKU
Read
Premarket Biotech Digest – PFE Receives EU Approval, ALKS Announces Positive Results, SRNE Receives FDA Approval
Article By: KKD Healthcare Analytics
Friday, June 30, 2017 9:30 AM EDT
Pfizer Inc. announced receiving the European Commission’s approval for Besponsa treatment for adults with relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leukemia.
In this article: MYOV, PFE, ALKS, SRNE, EIGR, WBA, LH, CTMX
Read
All Posts

Latest Tweets for $EIGR

No tweets yet!

PARTNER HEADLINES